Pragmatic Clinical Trials in 2024 | Cromos Pharma
Pragmatic Clinical Trials in 2024 Pragmatic clinical trials (PCTs) stand as a transformative approach in the biotech and pharmaceutical industries, providing crucial real-world insights into treatment effectiveness within the contexts where they are expected to be applied. Unlike explanatory trials that focus on controlled and specific biological outcomes, PCTs delve into the applicability and generalizability of interventions across diverse clinical Read more
Clinical Research Focus 24th edition | Cromos Pharma
Clinical Research Focus. 24th Edition Key Highlights in Clinical Research and Healthcare for 2023 As we bid farewell to 2023, a significant year in clinical research, we reflect on the transformative strides and pivotal trends that have shaped the landscape of medical research. This article explores some of the significant developments that have unfolded, bringing fresh insights and innovations to Read more
Key Insights from ASH 2023 | Cromos Pharma
Exploring Groundbreaking Advances: Key Insights from ASH 2023 The American Society of Hematology (ASH) 2023 conference, a cornerstone event in the field, has lived up to expectations by unveiling a multitude of groundbreaking developments. It has proven to be an extraordinary platform, revealing a plethora of discoveries and advancements poised to redefine the landscape of hematological research and patient care. As the author Read more
Key Highlights in Clinical Research and Healthcare for 2023 | Cromos Pharma
Key Highlights in Clinical Research and Healthcare for 2023 As we bid farewell to 2023, a significant year in clinical research, we reflect on the transformative strides and pivotal trends that have shaped the landscape of medical research. This article explores some of the significant developments that have unfolded, bringing fresh insights and innovations to the biotech and pharma community. 1. Revision of the Read more

TO FIND OUT MORE

INQUIRY@CROMOSPHARMA.COM